Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Sylvia Mitchell is a leading clinical researcher in head and neck oncology, whose work has fundamentally shaped the treatment landscape for oropharyngeal squamous cell carcinoma (OPSCC). Her primary research areas include comparative effectiveness of radiotherapy and transoral robotic surgery, with a focus on optimizing curative-intent therapies while preserving patient quality of life. Dr. Mitchell is best known for her pivotal role in the ORATOR randomized trial, which directly compared radiotherapy versus transoral robotic surgery for OPSCC. The final results of this landmark study, published in 2024 and garnering 37 citations, provided critical evidence on survival outcomes and functional toxicities between these two modalities, influencing clinical guidelines worldwide. Her contributions have helped resolve long-standing debates in the field, offering patients and clinicians data-driven clarity on treatment selection. With a career dedicated to rigorous trial design and patient-centered outcomes, Dr. Mitchell continues to drive innovation in head and neck cancer care, making her a highly respected authority whose work informs both current practice and future research directions.